Vanchinad Pharma Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
as on 17-06-2024
- Paid Up Capital ₹ 3.97 M
as on 17-06-2024
- Company Age 13 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 19.80 M
as on 17-06-2024
- Revenue 62.63%
(FY 2023)
- Profit 127.66%
(FY 2023)
- Ebitda 384.15%
(FY 2023)
- Net Worth 7472.96%
(FY 2023)
- Total Assets 57.51%
(FY 2023)
About Vanchinad Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 3.97 M.
The company currently has active open charges totaling ₹1.98 Cr.
Manoj Kumar, Sebastian Varghese, Joji Abraham, and Four other members serve as directors at the Company.
- CIN/LLPIN
U51397KL2011PTC029175
- Company No.
029175
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Aug 2011
- Date of AGM
27 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Kottayam, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Vanchinad Pharma?
Board Members(7)
Financial Performance and Corporate Structure Insights of Vanchinad Pharma.
Vanchinad Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 62.63% increase. The company also saw a substantial improvement in profitability, with a 127.66% increase in profit. The company's net worth Soared by an impressive increase of 7472.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vanchinad Pharma?
In 2023, Vanchinad Pharma had a promoter holding of 22.86% and a public holding of 77.14%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 31 May 2023 | ₹1.98 Cr | Open |
How Many Employees Work at Vanchinad Pharma?
Unlock and access historical data on people associated with Vanchinad Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
As of Mar 30, 2023, Vanchinad Pharma has raised a total of ₹ 5.19 M, with the most recent deal valued at ₹ 5.17 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
